PMID: 9635705Jul 4, 1998Paper

Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group)

International Journal of Radiation Oncology, Biology, Physics
S J ArnottZ Rugang

Abstract

The existing randomized evidence has failed to conclusively demonstrate the benefit or otherwise of preoperative radiotherapy in treating patients with potentially resectable esophageal carcinoma. This meta-analysis aimed to assess whether there is benefit from adding radiotherapy prior to surgery. This quantitative meta-analysis included updated individual patient data from all properly randomized trials (published or unpublished) comprising 1147 patients (971 deaths) from five randomized trials. With a median follow-up of 9 years, the hazard ratio (HR) of 0.89 (95% CI 0.78-1.01) suggests an overall reduction in the risk of death of 11% and an absolute survival benefit of 3% at 2 years and 4% at 5 years. This result is not conventionally statistically significant (p = 0.062). No clear differences in the size of the effect by sex, age, or tumor location were apparent. Based on existing trials, there was no clear evidence that preoperative radiotherapy improves the survival of patients with potentially resectable esophageal cancer. These results indicate that if such preoperative radiotherapy regimens do improve survival, then the effect is likely to be modest with an absolute improvement in survival of around 3 to 4%. Trials or...Continue Reading

References

Jun 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S J ArnottW J Mackillop
Mar 1, 1985·Progress in Cardiovascular Diseases·S YusufP Sleight
Sep 1, 1988·Current Problems in Cancer·T R DeMeester, A P Barlow
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A Ajani
Mar 18, 1995·BMJ : British Medical Journal·M Clarke, L Greaves
Jan 14, 1995·BMJ : British Medical Journal·C Counsell, H Fraser

❮ Previous
Next ❯

Citations

Apr 6, 2001·Seminars in Surgical Oncology·F Wenz, H Mamon
Mar 20, 2010·Digestive Diseases and Sciences·Kaushik MukherjeeWael El-Rifai
Aug 29, 2003·Annales de chirurgie·P ThomasP Fuentes
Dec 11, 2003·The Journal of Thoracic and Cardiovascular Surgery·Thomas W RiceEugene H Blackstone
Feb 24, 2001·Current Problems in Cancer·R Wong, R Malthaner
Feb 24, 2000·La Revue de médecine interne·T ConroyP Wolff
May 10, 2000·International Journal of Radiation Oncology, Biology, Physics·L CortiK Beroukas
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·C HennequinC Maylin
Jun 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Kotaro GomiUNKNOWN Japanese Patterns of Care Study Working Subgroup of Esophageal Cancer
Jul 19, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R SylvesterL Duchateau
Jan 23, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J I Geh
Apr 12, 2003·Surgical Oncology·Brendan C VisserMarco G Patti
Jul 27, 2002·The Lancet Oncology·Carlos M GalmariniCharles Dumontet
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Stefan MichielsJean-Pierre Pignon
Apr 28, 2007·Nature Clinical Practice. Oncology·Lawrence KleinbergArlene A Forastiere
Mar 22, 2001·The British Journal of Surgery·J I GehR Glynne-Jones
Sep 11, 2002·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·J F BossetG Mantion
Dec 6, 2003·The New England Journal of Medicine·Peter C Enzinger, Robert J Mayer
Feb 24, 2001·American Journal of Clinical Oncology·A B JaniL M Chen
Oct 7, 2006·Current Opinion in Gastroenterology·J J Van LanschotP J Bakker
Nov 22, 2011·American Journal of Clinical Oncology·Sarahgene Gillianne DefoeJoel S Greenberger
Mar 10, 2001·Quality in Health Care : QHC·A MelvilleA Eastwood
May 28, 2011·Radiation Oncology·Maria C WolfFranz Zehentmayr
Dec 27, 2005·Annals of Surgical Oncology·Steven R DeMeester
Sep 28, 2010·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Nadim KhanMuzaffaruddin Sadiq
Jul 1, 2011·Journal of Visceral Surgery·D TougeronC Silvain
Jun 7, 2002·Gut·W H AllumUNKNOWN British Association of Surgical Oncology
Apr 21, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Bernhard Berger, Claus Belka
Jun 10, 2008·International Journal of Radiation Oncology, Biology, Physics·Amanda L SchwerTracey E Schefter
Mar 7, 2006·Gastroentérologie Clinique Et Biologique·Côme LepageJean Faivre
Dec 12, 2007·Best Practice & Research. Clinical Gastroenterology·Véronique VeuillezJean-François Seitz
May 30, 2006·Hematology/oncology Clinics of North America·Feng-Ming Spring KongJames A Hayman
Dec 5, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D P Cronin-FentonH Comber
Apr 20, 2007·Cancer Science·Yasuyuki SetoToshiharu Yamaguchi
Sep 29, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Z ZhangX Zou
Oct 23, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·B L D M BrücherJ R Siewert
Nov 24, 2004·Annales de chirurgie·C Mariette, J P Triboulet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.